Page last updated: 2024-08-23

alpidem and ssr180575

alpidem has been researched along with ssr180575 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benavides, J; Bourliaud, G; Brault, E; Claustre, Y; Ferzaz, B; Fournier, J; George, P; Liere, P; Marabout, B; Marguet, F; Nowicki, JP; Poughon, G; Robert, JP; Scatton, B; Schumacher, M; Sevrin, M; Soubrie, P1

Other Studies

1 other study(ies) available for alpidem and ssr180575

ArticleYear
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:3

    Topics: Acetamides; Aging; Animals; Anti-Anxiety Agents; Axotomy; Binding, Competitive; Cell Survival; Facial Nerve; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; Imidazoles; Indoles; Ligands; Male; Motor Neurons; Neuroprotective Agents; Pyridazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A

2002